360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Biotie Therapies Oyj

Type: Company

Name: Biotie Therapies Oyj (Biotie Therapies Corp)

Fact Sheet: Fact Sheet for Biotie Therapies Corp

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Phase II

Biotie puts cocaine dependence drug into Phase II

Following in the footsteps of Selincro, its recently-launched drug to cut alcoholic urges, Biotie Therapies Corp has started a mid-stage study of nepicastat for cocaine dependence.The Finnish drugmaker noted that an 11-week Phase II study, with funding ... [Published Pharma Times - May 13 2013]

Entities: Biotie Therapies Oyj, Cocaine, Phase II

First reported May 10 2013 - Updated May 10 2013 - 3 reports

Biotie announces start of clinical study with n...

Biotie announces start of clinical study with nepicastat (SYN117) in cocaine dependence ... [Published MoneyAM - May 10 2013]

Entities: Biotie Therapies Oyj, clinical study, Cocaine

First reported May 09 2013 - Updated May 09 2013 - 3 reports

The European Alcohol Addiction Market is Poised For a Treatment Paradigm Shift With the Launch of BioTie/Lundbeck's Selincro

BURLINGTON, Mass.(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )The DecisionBase 2013 report entitled also finds that surveyed U.S. psychiatrists indicated that they would prescribe Alkermes' samidophan to 25 percent of their patients ... [Published Bio-Medicine - May 09 2013]

Entities: Biotie Therapies Oyj, Selincro, Alcohol

First reported May 08 2013 - Updated May 08 2013 - 1 reports

H Lundbeck AS

Selincro launched in the UK

Biotie has announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the UK. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, Biotie is eligible for a milestone payment of â‚¬2 million related ... [Published Hospital Pharmacy Europe - May 08 2013]

Entities: Selincro, Biotie Therapies Oyj, United Kingdom, H Lundbeck AS, Alcohol

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Cartus

Cartus Removes the Guesswork When It Comes to Determining How Much It Costs a Company to Transfer an Employee Globally

International Quick Cost Projection Tool Helps Companies Quickly Determine 'What If' Relocation Scenarios for More Than 70 CountriesCartus Corporation, a leading provider of global relocation services, has launched the newest version of its popular web-based ... [Published NewsBlaze - May 06 2013]

Entities: Cartus, Biotie Therapies Oyj, OneShield Inc, Transfers, Selincro

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Fleetwood Enterprises Inc

Excelerate Offers Valuable Strategies to Eliminate Bad Habits and Become an Effective Virtual Communicator

Spring-Cleaning Your Virtual-Communication HabitsKimberly Gerber, a renowned communications expert and president/CEO of Excelerate, a communication training and coaching firm delivering innovative strategies and leadership development, has compiled a ... [Published NewsBlaze - May 06 2013]

Entities: Biotie Therapies Oyj, Selincro, Hard Creek Nickel Corp, Fleetwood Enterprises Inc, Mark Jarvis

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Biotie: Selincro launched in the United Kingdom

at 5.35 p.m. Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, Biotie is eligible for a milestone payment ... [Published Saudi Fransi Capital - May 06 2013]

Entities: Biotie Therapies Oyj, Selincro, United Kingdom, Alcohol, Timo Veromaa

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Biotie Therapies Turns To Profit In Q1 - Quick Facts

Biotie Therapies (BORPF.PK) reported net income of 10.0 million euros, verus a loss of 7.49 million euros last year. On a per share basis, earnings from continuing operations stood at 0.02 euros, as against a loss of 0.02 euros a year earlier.Quarterly ... [Published RTTNews.com - May 03 2013]

Entities: Biotie Therapies Oyj, UCB SA, A2A SpA, Selincro

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Biotie interim report 1 January - 31 March 2013 Thomson Reuters ONE

BIOTIE THERAPIES CORP. $ $ $ $ Stock Exchange Release $ $ 3 May, 2013 at 9.00 a.m.Biotie interim report 1 January - 31 March 2013;important clinical and regulatory milestones achieved Biotie` s partner H. Lundbeck A/S (Lundbeck) received European marketing ... [Published Yahoo! Finance - May 03 2013]

Entities: Biotie Therapies Oyj, UCB SA, Selincro

First reported Apr 22 2013 - Updated Apr 22 2013 - 2 reports

Biotie: Selincro launched in first European markets (Biotie Therapies Oyj)

Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has started launching Selincro(TM) in the first European markets, making the new treatment available to alcohol dependent patients in Norway, Finland, Poland and the Baltic countries. The ... [Published Presscontacts.com - Apr 22 2013]

Entities: Biotie Therapies Oyj, Selincro, Alcohol, Timo Veromaa, H Lundbeck AS

First reported Apr 04 2013 - Updated Apr 04 2013 - 1 reports

BIOTIE THERAPIES OYJ:N VARSINAISEN YHTIÖKOKOUKSEN PÄÄTÖKSET JA HALLITUKSEN JÄRJESTÄYTYMINEN

BIOTIE THERAPIES OYJ PÖRSSITIEDOTE 4.4.2013 klo 11.45BIOTIE THERAPIES OYJ:N VARSINAISEN YHTIÖKOKOUKSEN PÄÄTÖKSET JA HALLITUKSENJÄRJESTÄYTYMINENBiotie Therapies Oyj:n varsinainen yhtiökokous pidettiin 4.4.2013.Tilinpäätöksen vahvistaminen ... [Published GlobeNewswire - Apr 04 2013]

Entities: Biotie Therapies Oyj

First reported Mar 02 2013 - Updated Mar 03 2013 - 1 reports

Biotie's partner H. Lundbeck receives European marketing authorization for Selincro

The European Commission has granged EU marketing authorization for H.Lundbeck's Selincro (nalmefene; an opioid system modulator) for the reduction of alcohol consumption in adult patients with alcohol dependence. The marketing authorization applies to ... [Published PharmaBiz - Mar 02 2013]

Entities: Selincro, Biotie Therapies Oyj, H Lundbeck AS

Quotes

"The market for alcohol addiction therapies remains very small despite the relatively high prevalence of the disease because of low diagnosis and drug treatment rates" said Decision Resources Analyst Natalie Taylor About Decision Resources Decision Resources (www.decisionresources...

The European Alcohol Addiction Market is Poised For a Treatment Paradigm Shift With the Launch of ... [Published PR Newswire - May 09 2013]

"The recently enhanced Cartus International Quick Cost Projection Tool allows companies to quickly generate high-level cost projections with minimal data entry. The tool is a cost-effective way for both large and small companies to enhance their international pre-assignment planning, and helps them more effectively plan and manage their global workforce" said Brooks Neitzke, Director, International Assignment Compensation Services for Cartus

Cartus Removes the Guesswork When It Comes to Determining How Much It Costs a Company to Transfer ... [Published NewsBlaze - May 06 2013]

Biotie's President and CEO said, "The first quarter was marked by two important developments for Biotie: the approval of Selincro in Europe, the first and only product labeled for reduction of alcohol intake, and a continued commitment from our partner UCB Pharma to advance our novel A2A receptor antagonist - tozadenant - for Parkinson's disease into Phase 3 trials."

Biotie Therapies Turns To Profit In Q1 - Quick Facts [Published RTTNews.com - May 03 2013]

...Lundbeck will provide the drug as part of "a novel treatment concept" which includes "continuous psychosocial support focused on the reduction of alcohol consumption and treatment adherence" . It has been developed for use on an as-needed basis, taken on days when the patient feels a risk of drinking

Lundbeck heads north for first launches of anti-alcohol drug [Published Pharma Times - Apr 23 2013]

More Content

sort by: Date \| Relevance
Biotie puts cocaine dependence drug into Phase II [Published Pharma Times - May 13 2013]
Deals of the Week: With Option Deal, Forest Kee... [Published The IN VIVO Blog - May 10 2013]
Biotie Announces Start of Clinical Study With N... [Published Marketwire - Breaking News Releases - May 10 2013]
Biotie announces start of clinical study with n... [Published MoneyAM - May 10 2013]
Biotie: Kliininen tutkimus nepikastaatilla (SYN... [Published GlobeNewswire: Acquisitions News - May 10 2013]
Biotie announces start of clinical study with n... [Published GlobeNewswire: Acquisitions News - May 10 2013]
Biotie announces start of clinical study with n... [Published NASDAQ OMX - May 10 2013]
Biotie Therapies Oyj: Biotie announces start of... [Published FinanzNachrichten.de - May 10 2013]
The European Alcohol Addiction Market is Poised... [Published Bio-Medicine - May 09 2013]
The European Alcohol Addiction Market is Poised... [Published NewsBlaze - May 09 2013]
The European Alcohol Addiction Market is Poised... [Published PR Newswire - May 09 2013]
The European Alcohol Addiction Market is Poised... [Published PR Newswire: Health - May 09 2013]
UK launch for Lundbeck's alcohol dependency dru... [Published Pharma Times - May 09 2013]
Selincro launched in the UK [Published Hospital Pharmacy Europe - May 08 2013]
Cartus Removes the Guesswork When It Comes to D... [Published NewsBlaze - May 06 2013]
Hard Creek Nickel Adopts Advance Notice Policy ... [Published NewsBlaze - May 06 2013]
OneShield Helps Insurers Capitalize on New Grow... [Published NewsBlaze - May 06 2013]
Biotie: Selincro Launched in the United Kingdom [Published NewsBlaze - May 06 2013]
Frightened Rabbit to Join The National on Tour ... [Published NewsBlaze - May 06 2013]
STWA Strategic Objectives Update [Published NewsBlaze - May 06 2013]
Excelerate Offers Valuable Strategies to Elimin... [Published NewsBlaze - May 06 2013]
Biotie: Selincro Launched in the United Kingdom [Published Marketwire - Breaking News Releases - May 06 2013]
Biotie: Selincro launched in the United Kingdom [Published GlobeNewswire: Advertising News - May 06 2013]
Biotie: Selincro markkinoille Iso-Britanniassa [Published GlobeNewswire: Advertising News - May 06 2013]
Biotie: Selincro launched in the United Kingdom [Published Saudi Fransi Capital - May 06 2013]
Change in the number of votes relating to Bioti... [Published GlobeNewswire: Acquisitions News - May 06 2013]
Biotie Therapies Oyj:n osakkeiden tuottaman ään... [Published GlobeNewswire: Acquisitions News - May 06 2013]
Biotie Therapies Turns To Profit In Q1 - Quick ... [Published RTTNews.com - May 03 2013]
Biotie interim report 1 January - 31 March 2013... [Published Yahoo! Finance - May 03 2013]
Biotie osavuosikatsaus tammi- maaliskuu 2013 [Published GlobeNewswire: Advertising News - May 03 2013]

Blogs

sort by: Date \| Relevance
Deals of the Week: With Option Deal, Forest Kee... [Published The IN VIVO Blog - May 10 2013] It’s an optimistic time for pharma dealmakers, with the Dow and the Nasdaq Biotechnology Index climbing, buyers sitting on big piles of cash, and the IPO window as wide-open as it’s been in years. But for smaller companies that have long lamented that ...
Deals Of The Week: Elan Takes It All Off, Attra... [Published The IN VIVO Blog - Mar 04 2013] Elan Corp. PLC has been engaged in a slow motion strip-tease over the past five years; it has now shed so many assets that it may soon disappear entirely. On Feb. 25, Royalty Pharma fielded an $11/share, $6.5 billion bid for the company . That was ...
UCB licenses global rights to Tozadenant [Published PBR - News - Feb 28 2013] UCB has licensed exclusive worldwide rights to Biotie Therapies tozadenant (SYN115), a selective inhibitor of the adenosine 2a receptor, currently in development for the treatment of Parkinson's disease. ...

Press Releases

sort by: Date \| Relevance
Biotie Announces Start of Clinical Study With N... [Published Marketwire - Breaking News Releases - May 10 2013]
Biotie: Kliininen tutkimus nepikastaatilla (SYN... [Published GlobeNewswire: Acquisitions News - May 10 2013]
Biotie announces start of clinical study with n... [Published GlobeNewswire: Acquisitions News - May 10 2013]
The European Alcohol Addiction Market is Poised... [Published PR Newswire - May 09 2013]
The European Alcohol Addiction Market is Poised... [Published PR Newswire: Health - May 09 2013]